Case Study
Regulatory Submission Strategy and Novel Efficacy Endpoint for Treatment of an Ultra-Rare and ...
download
Veristat was brought in to create and manage a full development program for a gene therapy for a ...
A mid-size pharmaceutical company and its development partner, a small biotechnology company ...
A clinical-stage biopharmaceutical company came to Veristat with a complex statistical methodology ...
A client engaged the Veristat team in a Phase II study of intracerebral stem cell injection in ...
A clinical-stage biotechnology start-up asked Veristat to run a new European trial of their complex ...
A clinical-stage biotechnology start-up asked Veristat to run complex US and EU trials of their ...
Imagine you are getting ready to launch the third drug cohort of your early phase clinical trial ...
Veristat has collaborated with biopharmaceutical firms on the preparation of over 50 INDs. Learn ...
